People · Operator
Named in public records as an officer, director or promoter · active 2020–2025 · Biotechnology, Other, Business Services
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cedilla Therapeutics, Inc. | — | Biotechnology | Series C | $82.6M | $3.1B | 2020 |
| Adyton Resources Corp | — | Other | Seed | $3.0M | $8.3M | 2025 |
| Bowden Trucking, LLC | — | Business Services | Pre-Seed | $675K | $1.1M | — |
Chris Bowden at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Chris Bowden on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Eli Casdin | 1 | 6 |
| ABBIE CELNIKER | 1 | 6 |
| Jake Simson | 1 | 6 |
| Michael Gray | 1 | 6 |
| NEIL EXTER | 1 | 5 |
| Chirag Patel | 1 | 4 |
| Alexandra Glucksmann | 1 | 4 |
| Janessa Bowden | 1 | 1 |
| David Irvine | 1 | 1 |
| Tim Crossley | 1 | 1 |
| Sinton Spence | 1 | 1 |
| Dominik Naczynski | 1 | 1 |
| Rosana Kapeller | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.